Travellers with plans to stay in Mauritius for a long period of time may now qualify for a free Oxford-AstraZeneca Covishield vaccination.
The government of Mauritius will update it’s Covid-19 vaccination programmes to include long-term visitors to the islands, it was revealed last week.
Those travelling to the popular Indian Ocean destination with a premium visa who are 18 years of age plus will quality, as the country rolls out plans to reopen the borders fully.
Allowing non-nationals to stay for up to 12 months, anyone applying for Mauritius’s premium visa will need to prove plans for a long-term stay for the purpose of a vacation – not work – only. They will also need valid health and travel insurance.
Those planning to stay for less that 180 days will qualify for a tourist visa over a premium visa, however.
The decision to offer travellers the Oxford-AstraZeneca Covishield vaccine – the same being offered to citizens and residents –is the first of its kind.
At the time of writing, a lockdown has been imposed across the country in a bid to control the spread of Covid-19. But the move will be rolled out in hopes to boost international tourism when the borders do fully recopen.